DPP4 and Hypoglycemia: In contrast, a study by Fonseca et al. showed less hypoglycemia together with a decrease in HbA1c when vildagliptin was added to an insulin regimen [4], although this could not be confirmed in a study by Kothny et al., using the same DPP4-inhibitor [10].